GenomSys
About:
GenomSys is a Swiss health software company providing solutions for genomic data analyses to accelerate time to market for new applications.
Website: https://www.genomsys.com
Top Investors: EASME - EU Executive Agency for SMEs, Club degli Investitori, Eurostars, Elysian Capital LLP, Dolby Family Ventures
Description:
GenomSys is a Swiss health software company accelerating personalized genomics. As genomic applications are becoming widespread and data volumes are growing, there is a pressing need for data and process efficiency, interoperability, and software robustness. GenomSys offer a unique multi-infrastructure genomic platform, based on the ISO/IEC 23092 genomic standard (MPEG-G, "the MP3 for genomic data") we contributed to shape, enabling fast time-to-market of innovative applications with high potential. GenomSys solutions are cheaper (storage needs -70%), faster (4-month time-to-market of innovative application), interoperable, ready for mobile personal genomics, regulatory conscious.
$9.45M
$1M to $10M
Lausanne, Vaud, Switzerland
2016-03-01
info(AT)genomsys.com
Claudio Alberti
11-50
2019-09-16
Private
© 2025 bioDAO.ai